INO
Inovio Pharmaceuticals, Inc.
$1.21
+0.05 (+4.31%)
At close · Jul 7
Market Cap
$102.02M
Shares
82,273,237
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$65.34K
-70%
FY2025
Net Income
-$84.95M
+20.8%
FY2025
Operating Margin
-132871.32%
-81254.4pp
FY2025
Diluted EPS
-$1.81
+54.2%
FY2025
Operating Cash Flow
-$88.63M
+14.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $0 | $65.34K | $217.76K | $832.01K | $10.26M | $1.77M | $7.41M | $4.11M | $30.48M | $42.22M | $35.37M | $40.57M | $10.46M | $13.47M | $4.12M | $9.8M | |
| — | — | — | — | — | — | — | -$169.3K | — | — | — | — | — | — | — | — | |
| $52.19M | $54.21M | $75.62M | $86.68M | $187.65M | $249.24M | $94.25M | $88.02M | $95.26M | $98.57M | $88.71M | $57.79M | $34.1M | $21.37M | $17.98M | $20.03M | |
| $31.54M | $32.68M | $37M | $47.58M | $90.19M | $53.75M | $37.25M | $27.2M | $29.32M | $28.29M | $23.89M | $18.06M | $15.86M | $13.64M | $10.78M | $11.99M | |
| — | — | $0 | $145.42K | $496.49K | $520.42K | $547.08K | $1.07M | $1.25M | $1.62M | $1.38M | $870.2K | $942.72K | $1.77M | $1.82M | $1.87M | |
| — | — | — | — | — | — | — | $2.2M | — | — | — | — | — | — | — | — | |
| $83.72M | $86.89M | $112.62M | $144.77M | $277.84M | $302.99M | $131.49M | $115.22M | $124.57M | $125.86M | $111.6M | $74.86M | $49.95M | $33.01M | $27.61M | $31.43M | |
| -$83.72M | -$86.82M | -$112.4M | -$143.94M | -$267.57M | -$301.22M | -$124.08M | -$111.11M | -$94.09M | -$83.64M | -$76.24M | -$34.28M | -$39.5M | -$19.54M | -$23.49M | -$21.64M | |
| — | -132871.32% | -51616.91% | -17300.28% | -2607.35% | -16972.34% | -1674.25% | -2702.1% | -308.68% | -198.11% | -215.55% | -84.5% | -377.71% | -145.12% | -570.42% | -220.91% | |
| — | $0 | $177.83K | $1.22M | $1.25M | $1.94M | $8.7M | $7.95M | — | — | — | — | — | — | — | — | |
| $2.05M | $2.42M | $4.77M | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$2.93M | -$2.64M | -$3.16M | -$4.71M | -$3.86M | $343.37K | -$704.9K | $496.2K | — | — | — | — | — | — | — | — | |
| — | — | — | $0 | -$2.17M | -$434.39K | -$4.58M | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | -$588.27K | $476.37K | — | — | — | — | — | — | — | — | |
| — | -$84.95M | -$107.25M | -$135.12M | -$277.65M | -$303.22M | -$162.89M | -$120.81M | -$94.8M | -$88.21M | -$73.74M | -$31.2M | — | — | — | — | |
| — | $0 | $0 | $0 | $0 | $0 | $0 | -$257.34K | $2.17M | $0 | $0 | -$2.1M | $29K | $31K | $30K | — | |
| -$84.93M | -$84.95M | -$107.25M | -$135.12M | -$279.82M | -$303.66M | -$166.41M | -$119.36M | -$96.97M | -$88.21M | -$73.74M | -$29.19M | -$36.12M | -$66.03M | -$19.67M | -$15.25M | |
| — | -130000% | -49254.27% | -16239.87% | -2726.67% | -17109.87% | -2245.39% | -2902.75% | -318.12% | -208.92% | -208.49% | -71.94% | -345.44% | -490.29% | -477.56% | -155.72% | |
| — | — | — | — | $0 | $0 | -$1.06M | -$1.19M | — | $0 | $0 | $84.77K | -$18.42K | -$55.08K | -$44.03K | -$51.15K | |
| — | — | — | — | — | — | — | -$119.36M | -$96.97M | -$89.01M | -$73.74M | -$29.91M | -$38.3M | — | — | — | |
| -$84.91M | -$84.91M | -$107.27M | -$135.08M | -$280.23M | -$303.68M | -$167.14M | -$118.36M | — | -$89.65M | -$75.12M | -$26.14M | -$36.32M | -$66.23M | -$19.68M | -$15.27M | |
| USD/shares | — | -$1.81 | -$3.95 | -$6.09 | -$14.04 | -$17.40 | -$1.68 | -$14.52 | -$12.60 | -$12.96 | -$12.12 | -$5.16 | -$7.32 | — | — | — |
| USD/shares | — | -$1.81 | -$3.95 | -$6.09 | -$14.04 | -$17.40 | -$1.68 | -$14.52 | -$12.60 | -$13.08 | -$12.12 | -$5.28 | -$7.68 | — | — | — |
| shares | — | 46.89M | 27.16M | 22.17M | 19.89M | 17.4M | 12.93M | 8.23M | 7.71M | 6.81M | 6.1M | 5.68M | 4.93M | 15.36M | 11.38M | — |
| shares | — | 46.89M | 27.16M | 22.17M | 19.89M | 17.4M | 12.93M | 8.23M | 7.71M | 6.83M | 6.1M | 5.7M | 4.95M | 15.36M | 11.38M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Reportable Segments | $65,343 | $217,756 | $832,010 |
By Product & Service (USD)
| Component | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|
| License | $902,260 | $5,170,586 | $3,636,945 | $29,860,785 |
| Other Revenue | $627,188 | $786,904 | $237,536 | $171,588 |
| Licensewith Affiliated Entities | $245,310 | $1,453,730 | $235,649 | $449,524 |
| Other Revenue Affiliated Entity | $0 | $0 | $1,800 | $0 |